Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium chloride reabsorption is a fundamental physiological process in the kidneys, responsible for reclaiming filtered sodium and chloride ions from the renal tubular fluid back into the bloodstream. This process is essential for maintaining extracellular fluid volume, blood pressure, and electrolyte balance. Key transporters involved include NHE3, SGLT, NKCC2, NCC, and ENaC. Regulation is achieved through hormones like aldosterone and factors like plasma potassium and the WNK-SPAK kinase pathway. Disorders affecting this system can lead to hypertension, hypotension, and electrolyte imbalances.
Varies depending on the specific transporter targeted. Examples include: inhibition of NKCC2 (loop diuretics), inhibition of NCC (thiazide diuretics), blockade of ENaC (potassium-sparing diuretics), and antagonism of aldosterone receptors (aldosterone antagonists).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium Chloride Reabsorption.